Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab in Males With Low Bone Mineral Density (ADAMO)
NCT00980174Phase 3Completed
- Sponsor
- Amgen
- Start
- Oct 2009
- Primary completion
- Jun 2011
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 3 trial of denosumab in osteoporosis, osteopenia, sponsored by Amgen. Started Oct 2009; status: completed.
02
Drugs
denosumab
03
Conditions
osteoporosisosteopenia
Beyond the preview
Go deeper on NCT00980174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00980174.